Skip to main content

Day: November 15, 2025

Linamar Completes Acquisition of Aludyne North America Assets

GUELPH, Ontario, Nov. 15, 2025 (GLOBE NEWSWIRE) — Linamar Corporation (TSX:LNR) today announced that its previously announced acquisition of select Aludyne North America assets has been completed. The deal was initially announced on October 9th for Linamar Corporation to acquire a substantial portion of Aludyne North America assets for $300 million USD. This acquisition is highly complementary to Linamar’s existing Structures and Chassis business, adding advanced capabilities in aluminum casting, precision machining, and product design. Aludyne’s portfolio includes knuckles, subframes, control arms, and axle housings, which aligns with Linamar’s strategic focus on propulsion-agnostic structural components. Upon deal completion, these Aludyne North America facilities will be integrated into the Linamar Structures Group, part of...

Continue reading

Mantiqueira USA Announces Acquisition of Hickman’s Egg Ranch, Marking U.S. Expansion

GREELEY, Colo., Nov. 14, 2025 (GLOBE NEWSWIRE) — Mantiqueira USA (MTQ USA) today announced it has entered a binding agreement to acquire Hickman’s Egg Ranch, a leading egg producer based in the Mountain and West Coast regions and ranked among the top 20 egg companies in the United States. The acquisition marks a significant milestone in MTQ USA’s launch and its long-term strategy to build a strong, scalable presence in the U.S. egg market. MTQ USA operates as a joint venture between the Pinto Family, founders of Mantiqueira, and JBS N.V. (NYSE: JBS), one of the world’s leading food companies.  “Expanding into the United States has long been a vision for our family, and taking this step through the acquisition of Hickman’s makes this moment especially meaningful,” said Leandro Pinto, Founder of Mantiqueira. “Hickman’s is a respected...

Continue reading

Algernon Closes First Tranche of its Recently Announced Private Placement Financing

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 14, 2025 (GLOBE NEWSWIRE) — Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, announces the closing of the first tranche (the “First Tranche”) of its non-brokered private placement (the “Offering”), previously announced on November 6, 2025. Gross proceeds from the First Tranche totaled CAD $177,000 from the sale of 2,528,752 units (the “Units”) at an issue price of CAD $0.07 per Unit. Certain insiders of the Company participated in the First Tranche of the Offering in the amount of CAD $37,000. The participation by insiders in the First Tranche of the Offering constitutes a “related party transaction” as defined under Multilateral...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.